Showing 1,656 news articles about Hepatitis & HIV

Filters Content type: Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis C treatment

Hepatitis C Drugs Will 'Strain Budgets': Study

Editor's pick
WebMD
17 March 2015
Hepatitis C treatment

Gilead's hepatitis C drugs largely cost-effective in US - study

Editor's pick
Reuters
17 March 2015
New & experimental hepatitis C treatment

FDA to review re-submitted Bristol-Myers hepatitis C drug

Editor's pick
Reuters
12 March 2015
Hepatitis B

WHO issues its first hepatitis B treatment guidelines

Editor's pick
World Health Organization
12 March 2015
Hepatitis C treatment

Hepatitis C pills drive surge in U.S. drug costs: report

Editor's pick
Reuters
12 March 2015
Hepatitis C treatment

Here Is Why Gilead Sciences, Inc. Is Still Doing Better Than AbbVie Inc

Editor's pick
Bidness
10 March 2015
Access to healthcare

$10 Copy of Gilead Blockbuster Sovaldi Appears in Bangladesh

Editor's pick
Bloomberg
9 March 2015
Access to healthcare

EECA CAB positions in regards to Janssen, BMS, Gilead and ViiV policy

Editor's pick
EATG
9 March 2015
Improving HIV care

NIH-led study to assess community-based hepatitis C treatment in Washington, D.C.

Editor's pick
EurekAlert
9 March 2015
Hepatitis C treatment

Natco Pharma ties up with Gilead on hepatitis C drugs

Editor's pick
Reuters
4 March 2015
Hepatitis C treatment

HCV Drugs Costly but Cure Might Not Be

Editor's pick
MedPage Today
4 March 2015
Hepatitis C treatment

Gilead's Harvoni gains NICE yes - but won't face funding delay

Editor's pick
PM Live
3 March 2015
Hepatitis C treatment

Delay HCV Tx and Watch Patients Die

Editor's pick
MedPage Today
2 March 2015
Hepatitis C treatment

Doctor Panel to Weigh Hepatitis C Drugs’ Costs in Guidelines

Editor's pick
Bloomberg
2 March 2015
Hepatitis C treatment

NICE guidance recommends sofosbuvir (Sovaldi, Gilead Sciences) and simeprevir (Olysio, Janssen) for treating hepatitis C

Editor's pick
NICE press release
26 February 2015
New & experimental hepatitis C treatment

New hepatitis C treatments highly effective for HIV/HCV coinfected people

Editor's pick
HIVandHepatitis.com
26 February 2015
Hepatitis C transmission & prevention

Sexual Transmission of HCV in Gay Men Should Not Be a PrEP Deterrent, Say Advocates

Editor's pick
The Body
26 February 2015
Hepatitis C treatment

Cost-Effectiveness of Immediate Hepatitis C Treatment in Early Disease Analyzed

Editor's pick
HCP Live
20 February 2015
Hepatitis C treatment

amfAR Report Examines Controversial Pricing of Hepatitis C Treatment

Editor's pick
amfAR
19 February 2015
Pharmaceutical industry

The Drug That Is Bankrupting America

Editor's pick
Huffington Post
18 February 2015
Hepatitis C symptoms & diagnosis

Study: Door-to-door campaign linked hepatitis C patients to care

Editor's pick
Eurekalert Inf Dis
16 February 2015
Pharmaceutical industry

Healthcare: The race to cure rising drug costs

Editor's pick
Financial Times
13 February 2015
New & experimental hepatitis C treatment

Health News Review analysis of Reuters' coverage of new hepatitis C drugs

Editor's pick
Health News Review
13 February 2015
Access to healthcare

UNITAID: 2015 Hepatitis C medicines technology and market landscape

Editor's pick
UNITAID
13 February 2015